Please login to the form below

Lucid celebrate big wins at PMEA 2015

Success for Lucid at PMEA 2015

Lucid group successfully supported AbbVie and Genzyme to win two awards at last night’s ceremony in London.

PEER (Psoriasis Expert Exchange FoRum) won the award for Excellence in Physicians/Healthcare Provider Support Programmes. This programme focussed on changing clinical behaviour on a global scale to improve standards of care in the management of psoriatic disease.

Commenting on the award, the judges said “The work around the Psoriasis Expert Exchange FoRum [PEER] showed an excellent understanding of the market and took a patient-centred approach from the outset. This was an ambitious programme reaching 3,200 physicians in 25 countries that achieved behavioural change which resulted in improved patient outcomes. A very comprehensive, sophisticated programme with great penetration. Congratulations to the AbbVie team.”

PEER epitomises Lucid group’s dedication to changing behaviour and improving patient outcomes.

Lucid also supported AbbVie to win the highly commended award in this category for its Treat to Target UK (T2TUK) programme. This programme focussed on driving implementation of the T2TUK recommendations across the UK.
And they celebrated with Genzyme after supporting them to win the award for launch excellence.

Lucid group were also proud to sponsor the award for Excellence in Continuous Development: Education Services for Global or Emerging Markets, which was won by Novo Nordisk for their Changing Diabetes in Children programme.

Dennis O’Brien Lucid group CEO commented 
“we are lucky to have a group of talented clients, who truly work in partnership with us to build programmes that make a difference.  It was great to be able to support them in their work and to celebrate their success with them”

26th November 2015



Company Details

Lucid Group Communications Limited

0345 0536671

Contact Website

First Floor, Jubilee House
Third Avenue
Globe Park

Latest content on this profile

Listen, learn and lift off

Lucid Group Communications Limited
Launch excellence

Lucid Group Communications Limited
Meet The Lucid Group Talent Team
Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your career to the next level with us, you can be assured that you'll have a whole group of people here cheering you on.So, if you’re feeling stuck or unfulfilled in your current role and looking for a company that will provide the personal and career development you need, please check out our open roles here: contact one of our talent acquisition managers for a chat:Ellen Field Assoc CIPDElaine DowneyJon TurnerDaniel Newbury
Lucid Group Communications Limited
Extraordinary lives: advancing change in rare diseases (Part 2)

Lucid Group Communications Limited
Extraordinary lives: advancing change in rare diseases (Part 2)
In support of Rare Disease Day, we're excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so important?Because 300 million people worldwide are living with a rare disease. This means that, collectively, the number of people living with a rare disease is equivalent to the population of the world's third-largest country (USA).While we have come a long way since the inception of Rare Disease Day, there's still plenty of work to do.Part 2 of this series focuses on important topics including the role of technology and the opportunities it presents for the rare disease community. The panel also hold captivating insights on how the pandemic has impacted the use of related digital technologies, the role of gene therapy, the major challenges and successes for pharma companies in supporting the rare disease community over the last 13 years, and much, much more.If you’d like to know more about the work we do in rare diseases or would like advice on any healthcare communication challenges please get in touch with Clare Reynolds on LinkedIn or by email: clare.reynolds@wearelucidgroup.comAbout Lucid GroupFounded in 2007, Lucid Group is a global multi-capability healthcare consultancy with core expertise in medical strategy, healthcare communications, creative and brand strategy, motion, digital and technology, behaviour change, metrics, and data analytics.  We partner with the pharma and biotech industry, delivering life-transforming value with connected capabilities to create pioneering solutions that change behaviour, improve clinical practice and advance health outcomes.  Transforming lives. Always.
Lucid Group Communications Limited
Extraordinary lives: advancing change in rare diseases (Part 1)

Lucid Group Communications Limited